|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's range||260.42 - 266.26|
|52-week range||208.48 - 287.94|
|Beta (3Y monthly)||1.06|
|PE ratio (TTM)||20.83|
|Earnings date||15 Apr 2019 - 22 Apr 2019|
|Forward dividend & yield||3.60 (1.39%)|
|1y target est||305.61|
NEW YORK, Jan. 17, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Stocks that moved substantially or traded heavily Tuesday: Netflix Inc., up $21.70 to $354.64 The video streaming company said it will raise prices for its U.S. subscribers. Microsoft Corp., up $2.96 to ...
UnitedHealth Group, the nation's largest insurer, reported earnings before the open on Tuesday that exceeded Wall Street expectations. UnitedHealth stock rose in early trade, giving a lift to Dow Jones futures.
Leerink’s Ana Gupte reiterated an Outperform rating on the stock and a $335 price target following the report. She writes that UnitedHealth turned in a “solid top- and bottom-line beat.”
Ryan McQueeney recaps Netflix's subscription price hike and earnings results from Delta, UnitedHealth, Wells Fargo, and JPMorgan. Later, he chats with Dave Bartosiak about bank earnings and how investors can profit throughout the Q4 report season.
UnitedHealth's fourth-quarter earnings slid 16 percent from last year, when a federal tax overhaul helped the nation's largest health insurer, but the performance still came in well above analyst expectations. Optum runs a large pharmacy benefit management business and a growing number of clinics and urgent care and surgery centers. UnitedHealth's insurance side, which generates more revenue but thinner profits, had flat operating earnings of $1.8 billion.
Currently, Q4 earnings season is heating up in earnest, with two top Wall Street banks and two other sector leaders bringing results ahead of the opening bell.
The tech-heavy Nasdaq composite led the way early Tuesday. Dow Jones stocks JPMorgan and UnitedHealth reported earnings results.
JPMorgan sagged, but Delta Air, Edwards Lifesciences and Netflix were early leaders as stocks rose ahead of the UK's critical Brexit vote.
UnitedHealth (UNH) delivered earnings and revenue surprises of 2.50% and 0.83%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
UnitedHealth Group Releases Stellar Fiscal 2018 ResultsPerformance in fiscal 2018 In UnitedHealth Group’s (UNH) fourth-quarter earnings release, the company announced its fiscal 2018 revenues of $226.2 billion—a rise of 12% YoY
Valeritas Holdings, Inc. (VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced that V-Go is Preferred on the OptumRx formulary. “We are very excited that V-Go is now Preferred on OptumRx formularies,” said Valeritas CEO, John Timberlake. “V-Go helps patients simplify their insulin therapy and improve their management of diabetes.